Business & Finance
AgenTus wins FDA approval for allogeneic iNKTs that may have potential to clear SARS-CoV-2 virus and mitigate harmful inflammation
3 June 2020 - Immuno-oncology company Agenus Inc (NASDAQ: AGEN) reported on Tuesday the receipt of the US FDA clearance for the IND application for an allogeneic iNKT therapy as the potential therapy ...
Poxel Successfully Raises EUR 17.7m in a Capital Increase
27 May 2020 - - French drugmaker Poxel S.A. (Euronext POXEL - FR0012432516) has raised EUR 17.7m in a private placement of 2,358,483 new ordinary shares, each with a nominal value of EUR 0.02 per shar...
Merck to pay USD0.61 per share dividend in Q3 2020
27 May 2020 - The board of directors biopharmaceutical company Merck (NYSE:MRK) declared a dividend of USD0.61 per share on the company's common stock for the second quarter of 2020, it disclosed...
Nordic Nanovector reports Q1 2020 financial results
26 May 2020 - Norway-based Nordic Nanovector ASA (OSE: NANO) has reported its financial results for the first quarter of 2020, it was reported on Tuesday.Revenues for the first quarter amounted to NOK...
Cardax reports financial results for Q1 2020
18 May 2020 - Cardax Inc (OTCQB:CDXI), a development stage biopharmaceutical company, has announced its financial results for the first quarter of 2020, it was reported on Friday.The company reported ...
Transgene and BioInvent Present Preclinical Data Demonstrating BT-001's Powerful Activity Against Solid Tumors
15 May 2020 - - French biotechnology company Transgene (Euronext Paris: TNG) has released new "highly promising" preclinical data demonstrating the broad therapeutic potential of BT-001...